Literature DB >> 17188925

Pregnane X receptor: promiscuous regulator of detoxification pathways.

Marko Matic1, Andre Mahns, Maria Tsoli, Anthony Corradin, Patsie Polly, Graham R Robertson.   

Abstract

The Pregnane X Receptor (PXR) is pivotal for the body's response to toxic xenobiotics and endogenous metabolites. By acting as a ligand-activated transcription factor, PXR regulates all stages of xenobiotic metabolism and transport and is responsible for important inductive drug interactions. Screening assays to assess the PXR activation potential of new and existing drugs are becoming integral components of drug discovery programs. PXR is also involved in lipid homeostasis providing opportunities for treatments based on PXR agonists for diseases involving aberrant cholesterol and bile acid levels. The expression of PXR in many other tissues besides liver and intestine suggest PXR may have additional protective functions in the body, which contribute to disease outcomes in diverse clinical situations with potential for novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188925     DOI: 10.1016/j.biocel.2006.08.017

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  22 in total

1.  Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.

Authors:  Yongjun He; Hua Yang; Tingting Geng; Tian Feng; Dongya Yuan; Longli Kang; Manling Luo; Tianbo Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders.

Authors:  Nagendra Kumar Chaturvedi; Sanjay Kumar; Seema Negi; Rakesh K Tyagi
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

3.  Opioid activation of toll-like receptor 4 contributes to drug reinforcement.

Authors:  M R Hutchinson; A L Northcutt; T Hiranita; X Wang; S S Lewis; J Thomas; K van Steeg; T A Kopajtic; L C Loram; C Sfregola; E Galer; N E Miles; S T Bland; J Amat; R R Rozeske; T Maslanik; T R Chapman; K A Strand; M Fleshner; R K Bachtell; A A Somogyi; H Yin; J L Katz; K C Rice; S F Maier; L R Watkins
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 4.  Nuclear receptor PXR, transcriptional circuits and metabolic relevance.

Authors:  Chibueze A Ihunnah; Mengxi Jiang; Wen Xie
Journal:  Biochim Biophys Acta       Date:  2011-02-02

5.  Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.

Authors:  Xue-Ding Wang; Jia-Li Li; Qi-Biao Su; Su Guan; Jie Chen; Jun Du; Yu-Wen He; Jun Zeng; Jin-Xin Zhang; Xiao Chen; Min Huang; Shu-Feng Zhou
Journal:  Br J Clin Pharmacol       Date:  2008-12-01       Impact factor: 4.335

Review 6.  Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.

Authors:  Yuzhi Jia; Navin Viswakarma; Janardan K Reddy
Journal:  Gene Expr       Date:  2014

Review 7.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

Review 8.  Why is neuroimmunopharmacology crucial for the future of addiction research?

Authors:  Mark R Hutchinson; Linda R Watkins
Journal:  Neuropharmacology       Date:  2013-06-11       Impact factor: 5.250

9.  Identification of pregnane X receptor ligands using time-resolved fluorescence resonance energy transfer and quantitative high-throughput screening.

Authors:  Sunita J Shukla; Dac-Trung Nguyen; Ryan Macarthur; Anton Simeonov; William J Frazee; Tina M Hallis; Bryan D Marks; Upinder Singh; Hildegard C Eliason; John Printen; Christopher P Austin; James Inglese; Douglas S Auld
Journal:  Assay Drug Dev Technol       Date:  2009-04       Impact factor: 1.738

10.  Study of the upregulation of the activity of cytochrome P450 3A isoforms by Astragalus injection and Astragalus granules in rats and in cells.

Authors:  Yongli Zhang; Ling Huang; Huichang Bi; Yuqiang Cui; Jingqing Li; Xiangsheng Wang; Xiaoling Qin; Jiangying Chen; Min Huang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-07-14       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.